Literature DB >> 29272413

Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection.

Evelyn Shaw1,2, Alexander Rombauts1, Fe Tubau3,4, Ariadna Padullés5, Jordi Càmara3, Toni Lozano5, Sara Cobo-Sacristán5, Núria Sabe1,2, Imma Grau1,4,6, Raül Rigo-Bonnin7, M Angeles Dominguez2,3,6, Jordi Carratalà1,2,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29272413     DOI： 10.1093/jac/dkx496

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  36 in total

1.  Successful Treatment of Bacteremia Due to NDM-1-Producing Morganella morganii with Aztreonam and Ceftazidime-Avibactam Combination in a Pediatric Patient with Hematologic Malignancy.

Authors:  Claire Amaris Hobson; Stéphane Bonacorsi; Mony Fahd; André Baruchel; Aurélie Cointe; Nora Poey; Hervé Jacquier; Catherine Doit; Audrey Monjault; Olivier Tenaillon; André Birgy
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 2.  [New β‑lactam antibiotics and β‑lactamase inhibitors against multidrug-resistant Gram-negative bacteria].

Authors:  Alexander Mischnik; Christoph Lübbert; Nico T Mutters
Journal:  Internist (Berl)       Date:  2018-12       Impact factor: 0.743

Review 3.  Past and Present Perspectives on β-Lactamases.

Authors:  Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 4.  Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline.

Authors:  Sara E Boyd; David M Livermore; David C Hooper; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

Review 5.  Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.

Authors:  David Aguilera-Alonso; Luis Escosa-García; Jesús Saavedra-Lozano; Emilia Cercenado; Fernando Baquero-Artigao
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 6.  Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.

Authors:  Olivia Smibert; Michael J Satlin; Anoma Nellore; Anton Y Peleg
Journal:  Curr Infect Dis Rep       Date:  2019-06-10       Impact factor: 3.725

7.  Searching for the Optimal Treatment for Metallo- and Serine-β-Lactamase Producing Enterobacteriaceae: Aztreonam in Combination with Ceftazidime-avibactam or Meropenem-vaborbactam.

Authors:  M Biagi; T Wu; M Lee; S Patel; D Butler; E Wenzler
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

Review 8.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

9.  Transplant tourism complicated by life-threatening New Delhi metallo-β-lactamase-1 infection.

Authors:  Jenell Stewart; Gretchen Snoeyenbos Newman; Rupali Jain; Andrew Bryan; Heather Berger; Martin Montenovo; Ramasamy Bakthavatsalam; Catherine E Kling; Lena Sibulesky; Sherene Shalhub; Ajit P Limaye; Cynthia E Fisher; Robert M Rakita
Journal:  Am J Transplant       Date:  2018-10-29       Impact factor: 8.086

10.  Genetic Features Leading to Reduced Susceptibility to Aztreonam-Avibactam among Metallo-β-Lactamase-Producing Escherichia coli Isolates.

Authors:  Mustafa Sadek; Mario Juhas; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.